Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Transforming Harvey (Ha) ras oncogene products accelerated the time course of Xenopus oocyte maturation induced by insulin, insulinlike growth factor 1, or progesterone. The transforming constructs, [Val-12]Ha p21 and [Val-12, Thr-59]Ha p21, displayed equal potency and efficacy in their abilities to accelerate the growth peptide-induced response. Normal Ha p21 was only 60% as powerful and one-fifth as potent as the mutants containing valine in the 12 position. In contrast, two nontransforming constructs, [Val-12, Ala-35, Leu-36, Thr-59]Ha p21 and [Val-12, Thr-59]Ha(term-174) p21, had no effect on the time course of hormone-induced maturation. Effects of the transforming ras proteins on hormone-induced maturation correlated with their abilities to stimulate in vivo phosphodiesterase activity measured after microinjection of 200 microM cyclic [3H] AMP. When p21 injection followed 90 min of insulin treatment, there was no increase in phosphodiesterase activity over that measured after hormone treatment or p21 injection alone, but additive effects of p21 and insulin on enzyme activity were observed during the first 90 min of insulin treatment. Even though normal Ha p21 and transforming [Val-12, Thr-59]Ha p21 stimulated oocyte phosphodiesterase to equal levels when coinjected with substrate at the initiation of the in vivo assay, the transforming protein elicited a more sustained stimulation of enzyme activity. These results suggest that stimulation of a cyclic AMP phosphodiesterase activity associated with insulin-induced maturation is involved in the growth-promoting actions of ras oncogene products in Xenopus oocytes.
Adari,
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
1988, Pubmed
Adari,
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
1988,
Pubmed Allende,
Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes.
1977,
Pubmed
,
Xenbase Baulieu,
Steroidal and peptidic control mechanisms in membrane of Xenopus laevis oocytes resuming meiotic division.
1983,
Pubmed
,
Xenbase Birchmeier,
ras proteins can induce meiosis in Xenopus oocytes.
1985,
Pubmed
,
Xenbase Broek,
Differential activation of yeast adenylate cyclase by wild-type and mutant RAS proteins.
1985,
Pubmed Calés,
The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product.
1988,
Pubmed Deshpande,
Insulin induction of Xenopus laevis oocyte maturation is inhibited by monoclonal antibody against p21 ras proteins.
1987,
Pubmed
,
Xenbase Finidori-Lepicard,
Progesterone inhibits membrane-bound adenylate cyclase in Xenopus laevis oocytes.
1981,
Pubmed
,
Xenbase Gibbs,
Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
1984,
Pubmed Gilman,
G proteins and dual control of adenylate cyclase.
1984,
Pubmed Goodhardt,
Does the guanine nucleotide regulatory protein Ni mediate progesterone inhibition of Xenopus oocyte adenylate cyclase?
1984,
Pubmed
,
Xenbase Hirai,
Induction of germinal vesicle breakdown in Xenopus laevis oocytes: response of denuded oocytes to progesterone and insulin.
1983,
Pubmed
,
Xenbase Hughes,
Are guanine nucleotide binding proteins a distinct class of regulatory proteins?
1983,
Pubmed Korn,
Ras p21 as a potential mediator of insulin action in Xenopus oocytes.
1987,
Pubmed
,
Xenbase Lacal,
Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21.
1987,
Pubmed
,
Xenbase Le Goascogne,
Induction of germinal vesicle breakdown in Xenopus laevis oocytes: synergistic action of progesterone and insulin.
1984,
Pubmed
,
Xenbase Le Goascogne,
Testosterone-induced meiotic maturation of Xenopus laevis oocytes: evidence for an early effect in the synergistic action of insulin.
1985,
Pubmed
,
Xenbase Maller,
Early effect of progesterone on levels of cyclic adenosine 3':5'-monophosphate in Xenopus oocytes.
1979,
Pubmed
,
Xenbase Manne,
Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.
1985,
Pubmed McGrath,
Comparative biochemical properties of normal and activated human ras p21 protein.
,
Pubmed O'Connor,
Inhibition of oocyte maturation by theophylline: possible mechanism of action.
1976,
Pubmed
,
Xenbase Olate,
Oocyte adenylyl cyclase contains Ni, yet the guanine nucleotide-dependent inhibition by progesterone is not sensitive to pertussis toxin.
1984,
Pubmed
,
Xenbase Papageorge,
A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene.
1986,
Pubmed Parada,
Presence of a Kirsten murine sarcoma virus ras oncogene in cells transformed by 3-methylcholanthrene.
1983,
Pubmed Sadler,
A similar pool of cyclic AMP phosphodiesterase in Xenopus oocytes is stimulated by insulin, insulin-like growth factor 1, and [Val12,Thr59]Ha-ras protein.
1989,
Pubmed
,
Xenbase Sadler,
Progesterone inhibits adenylate cyclase in Xenopus oocytes. Action on the guanine nucleotide regulatory protein.
1981,
Pubmed
,
Xenbase Sadler,
Identification of a steroid receptor on the surface of Xenopus oocytes by photoaffinity labeling.
1982,
Pubmed
,
Xenbase Sadler,
Inhibition of Xenopus oocyte adenylate cyclase by progesterone and 2',5'-dideoxyadenosine is associated with slowing of guanine nucleotide exchange.
1983,
Pubmed
,
Xenbase Sadler,
Progesterone inhibition of Xenopus oocyte adenylate cyclase is not mediated via the Bordetella pertussis toxin substrate.
1984,
Pubmed
,
Xenbase Sadler,
Inhibition of Xenopus oocyte adenylate cyclase by progesterone: a novel mechanism of action.
1985,
Pubmed
,
Xenbase Sadler,
In vivo regulation of cyclic AMP phosphodiesterase in Xenopus oocytes. Stimulation by insulin and insulin-like growth factor 1.
1987,
Pubmed
,
Xenbase Shih,
Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.
1980,
Pubmed Shih,
Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses.
1982,
Pubmed Sigal,
Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.
1986,
Pubmed Speaker,
Cyclic nucleotide fluctuations during steroid induced meiotic maturation of frog oocytes.
1977,
Pubmed Sweet,
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.
,
Pubmed Temeles,
Yeast and mammalian ras proteins have conserved biochemical properties.
,
Pubmed Thompson,
Multiple cyclic nucleotide phosphodiesterase activities from rat brain.
1971,
Pubmed Toda,
In yeast, RAS proteins are controlling elements of adenylate cyclase.
1985,
Pubmed Trahey,
A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants.
1987,
Pubmed
,
Xenbase Willumsen,
Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains.
1985,
Pubmed Willumsen,
The p21 ras C-terminus is required for transformation and membrane association.
,
Pubmed
